⌘K

Login Start Free

Home/Filings/4/0000950170-24-028861

4//SEC Filing

Hamdy Ahmed MD 4

Accession 0000950170-24-028861

CIK 0001796129other

View on SEC.gov Company Profile

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 8:00 PM ET

Size

5.3 KB

Accession

0000950170-24-028861

Insider Transaction Report

Form 4

Period: 2024-03-07

Vincerx Pharma, Inc.VINC

DirectorPresident and CEO10% Owner

Transactions

Award
Stock Option (right to buy)
2024-03-07+146,746→ 146,746 total
Exercise: $7.38Exp: 2034-03-06→ Common Stock (146,746 underlying)

Footnotes (1)

[F1]One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Vincerx Pharma, Inc.

CIK 0001796129

Entity typeother

Related Parties

1

filerCIK 0001458506

Filing Metadata

Form type: 4
Filed: Mar 7, 7:00 PM ET
Accepted: Mar 8, 8:00 PM ET
Size: 5.3 KB

View on SEC.gov